Conservative commentator Megyn Kelly claimed the Pfizer COVID vaccine left her with an auto-immune disorder in explosive new comments on her latest podcast episode Wednesday. Kelly, 54 ...
Note: This story has been corrected to clarify that Talis Biomedical did not file for bankruptcy in 2024 but is no longer an operating company. We regret the error ...
After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., is returning to her previous employer: Big Pharma Pfizer. After ...
It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer. Pfizer’s decision to hire Patrizia Cavazzoni, a former top drug ...
Pfizer's disclosure Friday that it is ending global development and commercialization efforts for its hemophilia B treatment Beqvez brings an inauspicious ending to a gene therapy that got its ...
Patrizia Cavazzoni, formerly the top regulator of the drug division of the Food and Drug Administration, will join Pfizer as chief medical officer, a role in which she will lead the drug firm’s ...
Der SC Freiburg schwimmt derzeit auf einer Erfolgswelle. Gegen Werder Bremen gelingt ein deutlicher Sieg mit Traumtoren. Der internationale Wettbewerb ist zum Greifen nah. Mit so vielen Toren dür ...
In an archived Facebook post claimed that Pfizer has released a list of side effects for COVID vaccine. In a post by Courtney June is captioned as, "Karma has no expiration date. PFIZER JUST RELEASED ...
Von Alexa Joline Horn Sie spielen mit Licht und musikalischen Brüchen: Ätna macht auf seiner Europa-Tour Halt im Jazzhaus in Freiburg. Das Elektro-Pop-Duo liefert eine abwechslungsreiche Show ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...
NEW YORK/TOKYO -- Pfizer will end global development and commercialization of Beqvez, a gene therapy for hemophilia, after the drugmaker dropped its other similar treatment for the disorder in ...
Pfizer will no longer develop and commercialize its hemophilia B gene therapy Beqvez across all of its global markets, according to multiple media reports Thursday. In a statement to Nikkei Asia, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results